Longboard Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thank you for joining the next session with Longboard Pharmaceuticals. I'm Ami Fadia, one of the biotech analysts here at Needham. We're fortunate enough to have Brandi Roberts, CFO of the company, sharing with us an overview of the company. I just wanted to also remind our listeners that if you'd like me to ask any questions on your behalf, please send it over to me through the dashboard.
With that, Brandi, over to you, and we'll take some time at the end for Q&A.
Great. Thanks so much, Amy, and thanks to the Needham team for hosting today. Really appreciate it.
Before I get started, I do want to remind listeners that I will be making some forward-looking statements today. So for additional information, please check out our SEC filings that are available on our website as well as sec.gov.
I'd like to start off with our history. We have a pretty unique history as a company. We were founded by
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |